Phenoxyacetamide structural analogues of Chlodantane and ADK-918

What does this source report?

The patent explicitly identifies its two adamantane-containing phenoxyacetamides as structural analogues of ADK-910 and ADK-918. This documents a later medicinal-chemistry branch, not demonstrated clinical superiority.

Population and setting

Preclinical research; no human efficacy established

Evidence type

Patent / reported experiments

Preparation

See the original report; formulation details require verification.

Source language

English

Title provenance

Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

• Chemistry and preclinical observations do not establish human efficacy or safety.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Source identity and selected abstract or text passages checked; complete methods not appraised.

Recorded source-check date: 2026-10-03. This date does not imply a completed systematic review.

Open original source or index record ↗

Cite and trace this record

Original source: Author unconfirmed. Phenoxyacetamide structural analogues of Chlodantane and ADK-918 RU2660654C1; Volgograd State Technical University 2018.

Molekul research summary: https://molekul.io/research/adk-phenoxyacetamides-2018. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Related compound profiles